Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Parker

Showing results (21-30 of 64) with videos related to

Pageof 7
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 12, 2018
Characteristics of Large Mumps Outbreaks in the United States, July 2010-December 2015Nakia S Clemmons, Susan B Redd, Paul A Gastañaduy, et al.
The Journal of Infectious Diseases|October 9, 2010
Measles in the United States during the postelimination eraAmy Parker Fiebelkorn, Susan B Redd, Kathleen Gallagher, et al.
Physiological Genomics|January 30, 2004
DNA microarray analysis of gene expression in human optic nerve head astrocytes in response to hydrostatic pressurePing Yang, Olga Agapova, Amy Parker, et al.
Social Science & Medicine (1982)|April 14, 2012
Systematic review of behavior change research on point-of-use water treatment interventions in countries categorized as low- to medium-development on the human development indexAmy Parker Fiebelkorn, Bobbie Person, Robert E Quick, et al.
American Journal of Public Health|August 18, 2017
Readiness to Vaccinate Critical Personnel During an Influenza Pandemic, United States, 2015Danielle L Moulia, Stephanie A Dopson, Sara J Vagi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 9, 2020
Adverse Events Among Young Adults Following a Third Dose of Measles-Mumps-Rubella VaccineMona Marin, Amy Parker Fiebelkorn, Daoling Bi, et al.
Journal of the American Medical Directors Association|July 6, 2026
Lessons Learned From an Immunization Quality Improvement Project Focused on Residents Living in Long-Term Care Settings, United States, 2022 to 2024Elizabeth A Sobczyk, Ellen M Schultz, David M Casey, et al.
American Journal of Epidemiology|March 25, 2017
Assessment of the Status of Measles Elimination in the United States, 2001-2014Paul A Gastañaduy, Prabasaj Paul, Amy Parker Fiebelkorn, et al.
Vaccine|August 16, 2018
Rubella virus neutralizing antibody response after a third dose of measles-mumps-rubella vaccine in young adultsHuong Q McLean, Amy Parker Fiebelkorn, Adaeze Ogee-Nwankwo, et al.
Health Promotion Practice|August 1, 2023
Operationalizing the Centers for Disease Control and Prevention's Vaccinate With Confidence Framework During the COVID-19 Emergency Response in the United StatesKathleen Holmes, Margaret Gutierrez-Nkomo, John Donovan, et al.
Pageof 7

Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 12, 2018
Characteristics of Large Mumps Outbreaks in the United States, July 2010-December 2015Nakia S Clemmons, Susan B Redd, Paul A Gastañaduy, et al.
The Journal of Infectious Diseases|October 9, 2010
Measles in the United States during the postelimination eraAmy Parker Fiebelkorn, Susan B Redd, Kathleen Gallagher, et al.
Physiological Genomics|January 30, 2004
DNA microarray analysis of gene expression in human optic nerve head astrocytes in response to hydrostatic pressurePing Yang, Olga Agapova, Amy Parker, et al.
Social Science & Medicine (1982)|April 14, 2012
Systematic review of behavior change research on point-of-use water treatment interventions in countries categorized as low- to medium-development on the human development indexAmy Parker Fiebelkorn, Bobbie Person, Robert E Quick, et al.
American Journal of Public Health|August 18, 2017
Readiness to Vaccinate Critical Personnel During an Influenza Pandemic, United States, 2015Danielle L Moulia, Stephanie A Dopson, Sara J Vagi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 9, 2020
Adverse Events Among Young Adults Following a Third Dose of Measles-Mumps-Rubella VaccineMona Marin, Amy Parker Fiebelkorn, Daoling Bi, et al.
Journal of the American Medical Directors Association|July 6, 2026
Lessons Learned From an Immunization Quality Improvement Project Focused on Residents Living in Long-Term Care Settings, United States, 2022 to 2024Elizabeth A Sobczyk, Ellen M Schultz, David M Casey, et al.
American Journal of Epidemiology|March 25, 2017
Assessment of the Status of Measles Elimination in the United States, 2001-2014Paul A Gastañaduy, Prabasaj Paul, Amy Parker Fiebelkorn, et al.
Vaccine|August 16, 2018
Rubella virus neutralizing antibody response after a third dose of measles-mumps-rubella vaccine in young adultsHuong Q McLean, Amy Parker Fiebelkorn, Adaeze Ogee-Nwankwo, et al.
Health Promotion Practice|August 1, 2023
Operationalizing the Centers for Disease Control and Prevention's Vaccinate With Confidence Framework During the COVID-19 Emergency Response in the United StatesKathleen Holmes, Margaret Gutierrez-Nkomo, John Donovan, et al.
Pageof 7